PD-L1 expression on tumor cells did not confer any advantage to the tumor for the colonization of this primary lymphoid organ, suggesting that PD-L1 expression on tumor cells may not provide sufficient protection against rejection by the host immune cells involved in hybrid resistance in this hematopoietic compartment (Figure 3B). The gene discussed is CD274; the disease is neoplasm.